7.380
7.38 (0%)
As of Dec 20, 2024
Iovance Biotherapeutics, Inc. [IOVA]
Source:
Company Overview
Iovance Biotherapeutics, Inc is a clinical-stage biopharmaceutical company pioneering a transformational approach to treating cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells using therapies personalized for each patient.
Country | United States |
Headquarters | san carlos, california |
Phone Number | (650) 260-7120 |
Industry | manufacturing |
CEO | Frederick G. Vogt |
Website | www.iovance.com |